Cme (CME) Depreciation & Amortization (CF) (2010 - 2026)

Cme (CME) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $28.2 million the latest figure, recorded in Q2 2026.

• Quarterly Depreciation & Amortization (CF) rose 3.3% year-over-year to $28.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $81.8 million (down 1.21% YoY) and the FY2025 annual result came in at $107.5 million, down 6.6% from the prior year.
• Depreciation & Amortization (CF) rose to $28.2 million in Q2 2026 per CME's latest filing, from $27.2 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for CME reached as high as $34.5 million in Q3 2022 and fell as low as $26.4 million in Q3 2025.
• A 5-year average of $30.0 million and a median of $29.4 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) retreated 11.15% — and 2026, when it rose 3.3%.
• Year by year, Depreciation & Amortization (CF) stood at $34.5 million in 2022, then declined by 9.86% to $31.1 million in 2023, then decreased by 9.32% to $28.2 million in 2024, then decreased by 6.38% to $26.4 million in 2025, then gained by 6.82% to $28.2 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $28.2 million, $27.2 million, and $26.4 million for Q2 2026, Q1 2026, and Q3 2025 respectively.